BioPort

Department of Defense renegotiates contract with Lansing, Mich.-based anthrax vaccine manufacturer BioPort, agreeing to pay $10.64 per dose, up from the previous $4.36 per dose (1"The Pink Sheet" July 26, p. 28). BioPort will also manufacture fewer doses, down to 5.3 mil. from 7.6 mil. The value of the new contract, which runs through 2005, is $49.8 mil., compared to $25.7 mil. under the old contract. In addition, DoD has agreed to make an advance payment of $18.7 mil. to the company so that it can pay its creditors